The owner of the United States' largest pharmacy benefit manager (PBM) is declining to cover Gilead Sciences’ long-acting HIV ...

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...

Gilead Sciences Inc. Chief Executive Officer Daniel O’Day said the company’s new HIV prevention drug Yeztugo should be able ...

In people with HIV infection, new-onset diabetes is independently predicted by higher leukocyte counts — mostly within the ...

The Gilead HIV prevention shot , called Yevtugo, is highly effective, but its list price is $28, 218 a year in the U.S.

Gilead stock toppled Thursday on a report CVS won't add the company's new HIV prevention drug, Yeztugo, to its commercial ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...

Honesty Bishop was attacked by her cellmate. Prison officials deemed her sexually active and kept her in isolation for more than 2,000 days.

Couples that were made up of 2 transgender women were less likely to contract HIV compared with couples that were made up of ...

The statement noted that their efforts would undoubtedly contribute to reducing stigma, increasing awareness and ensuring ...

This August, First Baptist Church in Austin hosts a memorial that renders that faith tangible.

The HIV and Faith conference is an event that will feature the premiere of the documentary 'Disrupting Stigma with Disrupting ...